Edition:
India

Spire Healthcare Group PLC (SPI.L)

SPI.L on London Stock Exchange

119.60GBp
24 Jun 2019
Change (% chg)

-2.50 (-2.05%)
Prev Close
122.10
Open
121.30
Day's High
123.00
Day's Low
119.00
Volume
137,857
Avg. Vol
787,633
52-wk High
259.25
52-wk Low
96.15

Summary

Name Age Since Current Position

Garry Watts

62 2017 Non-Executive Chairman of the Board

Justin Ash

2017 Chief Executive Officer, Executive Director

Martin Angle

69 2019 Deputy Chairman of the Board, Senior Independent Director

Jitesh Sodha

2018 Chief Financial Officer, Executive Director

John Forrest

2018 Chief Operating Officer

Daniel Toner

2015 General Counsel, Group Company Secretary

Antony Mannion

2019 Director, Strategy and Investor Relations

Peter Corfield

2018 Chief Commercial Officer

Jean-Jacques de Gorter

2018 Chief Medical Officer

Alison Dickinson

2018 Group Clinical Director

Simon Rowlands

62 2014 Non-Executive Director

Ronnie van der Merwe

55 2018 Non-Executive Director

Adele Anderson

2016 Independent Non-Executive Director

Anthony Bourne

2014 Independent Non-Executive Director

Janet Husband

76 2014 Independent Non-Executive Director

Jenny Kay

2019 Non-Executive Independent Director

Cora McCallum

2019 IR Contact Officer

Biographies

Name Description

Garry Watts

Mr. Garry Andrew Watts, FCA, MBE, is Non-Executive Chairman of the Board of the Company. He joined the Group as Executive Chairman in 2011 before becoming Non- Executive Chairman between Admission and March 2016. He again served as Executive Chairman between March 2016 and June 2017 before resuming his Non-Executive Chairman role in July 2017. The Company does not consider Garry to be independent due to his previous executive role. Current external appointments : chairman of BTG plc, chairman of Foxtons Group plc, non-executive director of Coca-Cola, European Partners Ltd. A chartered accountant by profession and former partner at KPMG, Garry’s extensive business knowledge and leadership on other listed company boards, including SSL International plc and Celltech Group plc, has ensured a seamless transition from private to public for the Company. He has a deep understanding of the healthcare sector having served as a member of the UK Medicines and Healthcare Products Regulatory Agency Supervisory Board for 17 years. Garry was also previously an executive director of Medeva plc, deputy chairman of Stagecoach Group plc and a non-executive director of Protherics plc.

Justin Ash

Mr. Justin Ash is Chief Executive Officer, Executive Director of the Company. Justin served as non-executive chairman of The New World Trading Company Co., chair of Independent Healthcare Providers Network. Justin was previously chief executive of Oasis Dental Care between 2008 and 2017 before leading its sale to Bupa. Prior to this, he was managing director of Lloyds Pharmacy and has held several other senior retail positions including general manager of KFC in the UK/ Ireland, and commercial director of Allied Domecq Spirits and Wines (Europe). Justin was previously a senior consultant with Bain and Company in London and Paris, and a nonexecutive board member and chair of the audit and risk committee of Al Nadhi Medical Company.

Martin Angle

Mr. Martin David Angle is Deputy Chairman of the Board, Senior Independent Director of the Company., effective 16 May 2019. Martin Angle is currently the senior independent director of Gulf Keystone Petroleum plc, vice chairman of the FIA Foundation and chairman of Cybersec Innovation Partners, a private cyber security company. He recently retired from the Boards of Pennon Group plc, and its separately regulated subsidiary South West Water, having completed 10 years on the Pennon Board. He has previously held a number of non-executive positions including Savills Plc (Senior Independent Director), National Exhibition Group (Chairman), Severstal, then a world top ten steel company listed in London, Dubai International Capital, and Shuaa Capital, then the only listed Gulf investment bank. In his earlier executive career, he held a number of senior positions in investment banking with SGWarburg & Co, Morgan Stanley and Kleinwort Benson, before becoming group finance director of TI Group plc, then a FTSE 100 with worldwide engineering activities. He subsequently joined Terra Firma Capital Partners as an Operating Managing Director where he held a number of senior roles in its portfolio companies including Le Meridien Hotel Group (executive deputy chairman and acting chairman) and the Waste Recycling Group (executive chairman), then one of the leading UK waste management businesses.

Jitesh Sodha

Mr. Jitesh H. Sodha is Chief Financial Officer, Executive Director of the Company. Jitesh graduated from New College, Oxford with a degree in Philosophy, Politics and Economics, and is a CIMA qualified accountant. He has worked in a range of businesses with an international footprint, most recently as Chief Financial Officer of De La Rue plc. He was previously Chief Financial Officer of Greenergy International, Mobilestreams Plc, where he led the IPO, and T-Mobile International UK.

John Forrest

Mr. John Forrest is Chief Operating Officer of the Company. John joins Spire from Greene King - the UK's leading pub retailer and brewer - where he has held a number of senior positions including COO for retail and most recently Managing Director for their Pub Partners division. Prior to Greene King, John was at Whitbread for eight years, including four years as COO of Premier Inn. Earlier in his career John worked for a number of major retailers.

Daniel Toner

Mr. Daniel Toner is General Counsel, Group Company Secretary of the Company. He joined Bupa Hospitals as head of legal in 2006 before being appointed General Counsel and Group Company Secretary upon Spire Healthcare’s formation in 2007 and is a solicitor by profession. He oversees all legal activity at Spire Healthcare, ensures compliance with statutory and regulatory requirements, and that decisions of the Board of Directors are realised. Daniel is also the Company’s Whistleblowing Officer. Daniel is an award-winning lawyer who brings considerable legal, commercial and healthcare experience to Spire Healthcare, having previously worked in both law firms (most recently Freshfields Bruckhaus Deringer), in businesses across a range of sectors and for the commercial directorate of the UK Department of Health.

Antony Mannion

Mr. Antony Mannion is Director, Strategy and Investor Relations of the Company. Antony Mannion joined Spire Healthcare as Investor and Public Relations Director in March 2012, having spent seven years at SSL International plc, until its acquisition by Reckitt Benckiser Group plc in 2010, as group legal director and head of acquisitions. Prior to SSL International plc, Antony worked as a corporate lawyer at Freshfields in London and Paris, then as an investment banker at Citicorp in London and New York, and at Standard Chartered in Singapore. Antony has a wide range of experience in all areas of corporate finance, and has worked on significant acquisition and IPO transactions in both the UK and overseas.

Peter Corfield

Mr. Peter Corfield is Chief Commercial Officer of the Company. Peter Corfield joined Spire Healthcare in October 2015 as Group Commercial Director and has responsibility for delivering revenue growth through our payor groups and identifying new business opportunities. He was appointed Chief Commercial Officer in January 2018 with additional responsibility for business development across the hospital portfolio. Prior to joining Spire Healthcare, he held a number of senior executive and board roles within the financial services industry in the UK, most recently as managing director of Ageas Retail Direct. Prior to this, Peter worked for both Zurich Financial Services Group and Royal Bank of Scotland in various roles that covered Europe, Middle East and Japan.

Jean-Jacques de Gorter

Dr. Jean-Jacques de Gorter (JJ) is Chief Medical Officer of the Company. Dr Jean-Jacques de Gorter joined Bupa Hospitals as director of clinical services in 2005 before being appointed Spire Healthcare’s Group Medical Director in 2007. He is responsible for driving the Group’s clinical governance, compliance and quality strategy. Prior to joining Bupa he served as a medical director for NHS Direct. Jean- Jacques has also been a non-executive director at the Milton Keynes University Foundation Trust, chairing its Quality Committee. He graduated from Charing Cross and Westminster Medical School, practised in the UK, Australia and New Zealand and subsequently completed his MBA at Cranfield School of Management.

Alison Dickinson

Simon Rowlands

Mr. Simon Rowlands is Non-Executive Director of the Company, since June 2014. He was appointed a Non- Executive Director in June 2014, although he served in a similar capacity prior to Admission having been an appointment of Cinven, the Company’s former principal shareholder. The Company does not consider Simon to be independent due to the senior position he held with Cinven. He is non-executive director of MD Medical Group Investment plc, founding partner of Africa Platform Capital. Simon’s extensive knowledge of the Company and its markets, combined with his wise counsel over a number of years, were among the reasons he was asked to continue to serve as a member of the Board following Cinven’s sale of their shareholding in 2015. He was a founding partner of the private equity firm Cinven until 2013, establishing and leading its healthcare team, and then served as a senior adviser until 2017. Simon founded a new private equity firm in 2016 focused on healthcare and consumer sectors of Sub- Saharan Africa. Prior to joining Cinven, he worked with an international consulting firm on multidisciplinary engineering projects in the UK and southern Africa.

Ronnie van der Merwe

Dr. Ronnie van der Merwe is Non-Executive Director of the Company. Dr Ronnie van der Merwe was appointed as a Non-Executive Director in May 2018. The Company does not consider Ronnie to be independent as he has been appointed to the Board by the Company’s principal shareholder, Mediclinic International PLC, under the terms of the relationship agreement with them. He is Chief executive officer of Mediclinic International PLC. Ronnie is a specialist anaesthetist who worked in the medical insurance industry before joining the Mediclinic Group in 1999 as Clinical Manager. He established the Clinical Information, Advanced Analytics, Health Information Management and Clinical Services functions at Mediclinic, and subsequently served as the Mediclinic Group’s Chief Clinical Officer. He was appointed as an executive director of Mediclinic International Limited in 2010 up to the combination of the businesses of the Company (then Al Noor Hospitals Group plc) and Mediclinic International Limited.

Adele Anderson

Ms. Adele Anderson is Independent Non-Executive Director of the Company. She serves as senior independent director and chair of the audit committee of intu properties plc, member of the audit committee of the Wellcome Trust. Adèle has gained extensive financial experience throughout her career and has significant knowledge of audit committees. Until July 2011, she was a partner in KPMG LLP and held a number of senior roles across their business including chief financial officer of KPMG UK, chief executive officer of KPMG’s captive insurer and chief financial officer of KPMG Europe. Adèle was a non-executive director of easyJet plc until February 2019.

Anthony Bourne

Mr. Anthony Rhys Bourne (Tony) is Independent Non-Executive Director of the Company, since June 2014. He serves as non-executive director of Barchester Healthcare Limited., non-executive director of Totally plc. Tony brings considerable knowledge of the healthcare industry to his role having been chief executive of the British Medical Association for nine years until 2013. Prior to this he was in investment banking for over 25 years, including as a partner at Hawkpoint and as global head of the equities division and a member of the managing board of Paribas. Tony has also previously served as a nonexecutive director of Bioquell Plc, Southern Housing Group, and the charity, Scope.

Janet Husband

Dame Janet Husband is Independent Non-Executive Director of the Company. His Current external appointments : Emeritus Professor of Radiology at the Institute of Cancer Research, senior adviser of Royal Marsden NHS Foundation Trust. Having trained in medicine at Guy’s Hospital Medical School, Dame Janet’s extensive career in healthcare allows her to bring invaluable insight and knowledge of the healthcare industry. She has previously served as a non-executive director of Royal Marsden NHS Foundation Trust, and was a specially appointed commissioner to the Royal Hospital Chelsea, was president of the Royal College of Radiologists, chaired the National Cancer Research Institute in the UK and was a non- executive director of Nuada Medical Group. Dame Janet was appointed as Professor of Diagnostic Radiology at the University of London, Institute of Cancer Research, in addition to more than 30 years as a practising consultant radiologist at the Royal Marsden Hospital.

Jenny Kay

Ms. Jenny Kay is appointed as Non-Executive Independent Director of the Company. Jenny Kay is currently a non-executive director (and senior independent director) at East London NHS Foundation Trust, a large combined mental health and community organisation providing services across East London, Luton and Bedfordshire. She was previously the Director of Nursing at Dartford and Gravesham NHS Trust in Kent (amongst other quality improvements, she strengthened the role of the ward sister, resulting in improvements in patient experience, safety and effectiveness on the wards). Jenny also worked at the Department of Health in the Chief Nursing Officer's team, leading on Communications. Additionally, Jenny has experience as Director of Quality in a Clinical Commissioning Group (CCG).

Cora McCallum